Ref ID: 18778
Author:
M. Nagao, PhD (Doctor of Philosophy), MD – Lecturer, G. Hotta, MD – Graduate student, M. Yamamoto, MD – Graduate student, Y. Matsumura, MD, PhD – Research associate, A. Matsushima, MD, PhD – Research associate, Y. Ito, MD, PhD – Research associate, S
Author address:
Kyoto Univ. Hosp., Kyoto, Japan.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: Candida bloodstream infection is associated with high morbidity and mortality in hospitalized patients. Most candida bloodstream infections are catheter related, but little is known about predictors of candidal catheter-related bloodstream infection (CRBSI). Objective: We conducted this study to determine risk factors that may predict Candida sp. as a causative agent among patients who were suspected to have a CRBSI. Methods: From January 2009 to December 2011, all patients with laboratory-confirmed CRBSI at Kyoto University Hospital were included in this study. We compared the clinical features of candidal CRBSIs and non-candidal CRBSIs. Results: We identified 78 candidal CRBSIs and 258 non-candidal CRBSIs. According to the univariate analysis, older age, solid malignancies, total parental nutrition, use of anti-anaerobic agents within 7 days, and placement of multiple intravenous/atrial catheters were common among candidal CRBSI, whereas hematological malignancies and post-transplantation status were less common (p<0.05). According to the multivariate analysis, solid malignancies (odds ratio (OR), 2.75; 95% confidence interval (CI), 1.54 - 4.90; p <0.001), total parental nutrition (OR, 2.86; 95% CI, 1.49 - 5.48; p =0.002), and use of anti-anaerobic agents (OR, 2.22; 95% CI, 1.03 - 4.79; p <0.001) were significantly more common among candidal CRBSI patients than among non-candidal CRBSI patients. The 1-3 β -D glucan test was positive among 94.5 % (35/37) of candidal CRBSI patients and 9% (10/106) of non-candidal CRBSI cases. Conclusion: Several factors such as solid malignancies, total parental nutrition and presence of multiple intravenous/atrial catheters may assist clinicians in assessing whether Candida sp. is a causative agent of CRBSI. Catheter removal and administration of antifungal agents may be considered for empiric therapy of CRBSI cases with those risk factors, especially when 1-3 β -D glucan tests are positive.
Abstract Number: K-949
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
C Gutierrez Perez1*, S Dhingra1,2, SM Kwansy3, TJ Opperman3, RA Cramer1
2022
93
-
v
PC Chatterjee1*, WC Chiu1, EBB Burgener2, PLB Bollyky3, JH Hsu1
2022
92
-
v
AS Serris1*, FU Uhel2, GMB Martin-Blondel3, OL Lambotte4, MEB Bougnoux5, EL Litvinova6, AO Ouedrani7, CR Rouzaud1, VB Bedarida8, JHR Raphalen9, FL Lanternier1,10
2022
91
-
v
ZA Lewis1, RB Meagher2*, S Ambati2, X Lin1
2022
90
-
v
QJ Choudhury1*, S Ambati2, X Lin1, ZA Lewis1, RB Meagher2
2022
-
v
M James1*, KW Liu1, E Vesley1, T Hohl2, RA Cramer1
2022
88
-
v
D Luptakova1, RH Patil1,2, V Havlicek1,2*
2022
87
-
v
EI Matthaiou1*, W Chiu1, C Conrad2, J Hsu1
2022
86
-
v
H Kamboj*, M Vijay, L Gupta, P Vijayaraghavan
2022
85
-
v
S Hartung1,2*, TNM Hoang1,2*, Z Cseresnyes3*, N Schuck1, K Rennert4,5, F Klos6, AS Mosig5,7, MT Figge3,8, M von Lilienfeld-Toal1,2
* Authors 1, 2 and 3 contributed equally
2022
84
